VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TPST
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TPSTTempest Therapeutics, Inc.
$0.99$4M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTPSTQuarterly Financials

Tempest Therapeutics, Inc. (TPST) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Tempest Therapeutics, Inc. (TPST) quarterly income statement — complete revenue, gross profit & net income history

TPST Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold22.18M0067K0000000000000000
COGS % of Revenue--------------------
Gross Profit-22.18M00-67K0000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses5.54M4.08M3.6M7.9M10.94M13.92M10.55M9.58M7.97M7.51M6.59M7.47M7.58M8.93M8.77M8.77M8.16M7.34M7.74M6.79M
OpEx % of Revenue--------------------
Selling, General & Admin5.42M3.54M3.03M4.09M3.31M3.18M2.99M3.75M3.63M3.33M2.37M3.05M2.9M3.14M2.8M3.12M3.05M2.62M3.11M2.56M
SG&A % of Revenue--------------------
Research & Development114K538K570K3.87M7.63M10.74M7.56M5.84M4.34M4.18M4.22M4.42M4.68M5.79M5.97M5.65M5.11M4.71M4.63M4.23M
R&D % of Revenue--------------------
Other Operating Expenses000-67K0000000000000000
Operating Income-27.72M-4.08M-3.6M-7.97M-10.94M-13.92M-10.55M-9.58M-7.97M-7.51M-6.59M-7.47M-7.58M-8.93M-8.77M-8.77M-8.16M-7.34M-7.74M-6.79M
Operating Margin %--------------------
Operating Income Growth %-153.47%70.71%65.91%16.86%-37.15%-85.23%-60.06%-28.27%-5.18%15.89%24.84%14.86%7.11%-21.75%-13.38%-29.31%-59.18%-69.74%-42.36%-29.53%
EBITDA-27.72M-4.01M-3.53M-7.9M-10.87M-13.87M-10.45M-9.43M-7.89M-7.43M-6.5M-7.39M-7.46M-8.72M-8.57M-8.66M-8.05M-7.24M-7.63M-6.7M
EBITDA Margin %--------------------
EBITDA Growth %-155.05%71.07%66.22%16.21%-37.81%-86.69%-60.73%-27.62%-5.77%14.78%24.11%14.72%7.41%-20.47%-12.33%-29.32%-59.5%-70.7%-42.52%-29.86%
D&A (Non-Cash Add-back)065K66K67K68K49K97K155K88K85K88K83K125K217K201K112K108K102K107K87K
EBIT-27.72M-4.02M-3.51M-7.82M-10.7M-13.57M-10.23M-9.2M-7.54M-7.11M-6.41M-7.23M-7.29M-8.67M-8.56M-8.7M-8.16M-7.44M-7.67M-6.78M
Net Interest Income-23K55K86K96K76K105K-5K12K70K11K-373K-111K-55K-106K-389K-394K-330K-441K-374K-273K
Interest Income055K86K142K237K352K324K384K438K388K0244K289K326K070K3K063K3K
Interest Expense23K0046K161K247K329K372K368K377K373K355K344K432K389K464K333K441K437K276K
Other Income/Expense23K56K86K96K76K105K-5K12K70K26K-194K-111K-55K-169K-176K-394K-330K-441K-374K-273K
Pretax Income-27.7M-4.02M-3.51M-7.87M-10.86M-13.81M-10.56M-9.57M-7.9M-7.49M-6.79M-7.58M-7.64M-9.1M-8.95M-9.17M-8.49M-7.78M-8.11M-7.06M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-27.7M-4.02M-3.51M-7.87M-10.86M-13.81M-10.56M-9.57M-7.9M-7.49M-6.79M-7.58M-7.64M-9.1M-8.95M-9.17M-8.49M-7.78M-8.11M-7.06M
Net Margin %--------------------
Net Income Growth %-155.03%70.89%66.74%17.76%-37.4%-84.47%-55.56%-26.24%-3.51%17.74%24.15%17.31%10.07%-17.02%-10.32%-29.9%-58.56%-80.07%-49.33%-34.98%
Net Income (Continuing)-27.7M-4.02M-3.51M-7.87M-10.86M-13.81M-10.56M-9.57M-7.9M-7.49M-6.79M-7.58M-7.64M-9.1M-8.95M-9.17M-8.49M-7.78M-8.11M-7.06M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-2.53-0.82-0.79-2.07-3.16-0.50-0.41-0.42-0.36-0.35-0.48-0.54-0.58-0.95-0.66-0.79-1.18-1.16-1.21-7.63
EPS Growth %19.94%-64%-92.68%-392.86%-777.78%-42.86%14.58%22.22%37.93%63.16%27.27%31.65%50.85%18.1%45.45%89.65%-45.68%75.16%-47.56%-865.82%
EPS (Basic)-2.53-0.82-0.79-2.07-3.16-0.50-0.41-0.42-0.36-0.35-0.48-0.54-0.58-0.95-0.66-0.79-1.18-1.16-1.21-7.63
Diluted Shares Outstanding10.93M4.15M4.44M3.8M3.44M27.9M25.81M22.55M22.23M21.52M14.12M14.1M13.76M10.52M13.64M11.57M7.17M6.72M6.72M925.43K
Basic Shares Outstanding10.93M4.15M4.44M3.8M3.44M27.9M25.81M22.55M22.23M21.52M14.12M14.1M13.76M10.52M13.64M11.57M7.17M6.72M6.72M925.43K
Dividend Payout Ratio--------------------